ArticleInvestigational new drugs2018

Exacerbation of autoimmune hemolytic anemia induced by the first dose of programmed death-1 inhibitor pembrolizumab: a case report.

Kenta Ogawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.